Inhibitors of the Platelet Thrombin Receptor Will They Live up to Their Promises ?

Abstract

Not that long ago, aspirin, heparin, and warfarin were the only available antithrombotic agents for treating cardiovascular disease patients at risk of thrombotic events. These agents are still used in several places around the world, and it is remarkable how difficult it was to discover other agents that are more effective and/or safer. Since the mid-1980s… (More)

Topics

Cite this paper

@inproceedings{Werf2011InhibitorsOT, title={Inhibitors of the Platelet Thrombin Receptor Will They Live up to Their Promises ?}, author={Frans Van de Werf}, year={2011} }